Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Closure of Trading Window

 Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Wednesday, June 24, 2020 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter ending June 30, 2020 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for information and record.
23-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Jubilant Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed.
22-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Issuance Of Commercial Papers Of Rs. 50 Crore

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 50 Crore on June 19, 2020.
19-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Clarification sought from Jubilant Life Sciences Ltd

 The Exchange has sought clarification from Jubilant Life Sciences Ltd on June 19, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
19-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rakesh Jhunjhunwala & PACs
16-06-2020
Bigul

Jubilant Life hits 52-week high on heavy volumes, soars 46% in 11 days

 The stock hit a 52-week high of Rs 646, up 8% today, surpassing its previous high of Rs 639, touched on January 23, 2020, on the BSE.
15-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Issuance Of Commercial Papers Of Rs. 50 Crore

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 50 Crore on June 12, 2020.
12-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Interaction With Debt Investors (Non-Deal Roadshow)

 Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, is participating in a Non-Deal Roadshow through video conferencing with select global debt investors on Friday, June 12, 2020. We enclose presentation to be shared with the debt investors in this regard. We request you to take the same on record.
11-06-2020
Bigul

Jubilant Life nears 52-week high, soars 41% in 8 days on strong Q4 results

 Jubilant Life Sciences reported 92 per cent year on year (YoY) jump in normalised profit after tax at Rs 260 crore in Q4FY20. Ebitda margin also improved to 23.7 per cent from 16.3 per cent in Q4FY19.
10-06-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Please find enclosed the Annual Secretarial Compliance Report dated June 5, 2020 for the financial year 2019-20.
06-06-2020
Next Page
Close

Let's Open Free Demat Account